Efficacy of External CounterPulsation for Postoperative Coronary Artery Bypass Grafting Patients
SEECABG
Study of Efficacy of External CounterPulsation on Reducing the Prevalence of Vein Graft Failure and Improving Cardiac Function for Postoperative Coronary Artery Bypass Grafting Patients
1 other identifier
interventional
120
1 country
1
Brief Summary
The aim of this study is to evaluate the effect of External CounterPulsation on postoperative heart function and vein graft failure rates of coronary artery bypass grafting patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2017
CompletedFirst Posted
Study publicly available on registry
August 1, 2017
CompletedStudy Start
First participant enrolled
September 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 7, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 7, 2021
CompletedSeptember 7, 2017
September 1, 2017
2.9 years
July 28, 2017
September 4, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
2-year vein graft patency rate
2-year vein graft patency rate determined by coronary CT angiography
Two years postoperatively
2-year major composite cardiovascular events (MACEs)
2-year major composite cardiovascular events,including STEMI/NSTEMI,readmission of heart attack, renal dialysis and acute heart failure
Two years postoperatively
Secondary Outcomes (2)
Canadian Cardiovascular Society (CCS) scoring
One and two years postoperatively
left ventricular end-systolic volume index (LVESVI) and Ejection Fraction
One and two years postoperatively
Study Arms (2)
ECP group
EXPERIMENTALPatients of ECP group are subjected to a standard ECP protocol one week postoperatively. A standard ECP protocol involves 35 one-hour sessions (once per day, 5 days a week) and continuous for 7 weeks. ECP consists of three sets of pneumatic cuffs attached to each of the patient's legs at the calf and lower and upper thigh. The inflation of the cuffs is triggered by a computer, and timing of the inflation is based on the R wave of the electrocardiogram. The ECP therapist adjusts the inflation and deflation timing to provide optimal blood movement per a finger plethysmogram waveform reading.
Control group
NO INTERVENTIONPatients of Control group received routine medicine treatment postoperatively
Interventions
ECP is a non-invasive method which consists of three sets of pneumatic cuffs attached to each of the patient's legs at the calf and lower and upper thigh. The inflation of the cuffs is triggered by a computer, and timing of the inflation is based on the R wave of the electrocardiogram. The ECP therapist adjusts the inflation and deflation timing to provide optimal blood movement per a finger plethysmogram waveform reading. This produces a retrograde flow of blood in the aorta resulting in a diastolic augmentation of blood flow and also an increase in venous return, which leads to an improved coronary perfusion pressure during diastole.
Eligibility Criteria
You may qualify if:
- Patients underwent coronary artery bypass grafting surgery
You may not qualify if:
- Cerebral hemorrhage within six months;
- Obvious aortic insufficiency;
- Aortic aneurysm;
- Aortic dissection;
- Coronary fistula or severe coronary aneurysm;
- Symptomatic Congestive heart failure
- New York Heart Association(NYHA)heart function class IV
- Valvular heart disease;
- Congenital heart diseases;
- Cardiomyopathies
- Uncontrolled hypertension, defined as SBP≥180mmHg or DBP≥110mmHg;
- Lower limb infection;
- Deep venous thrombosis;
- Progressive malignancies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mengya Lianglead
Study Sites (1)
Department of cardiac surgery, The first affiliated hospital of Sun Yat-sen university
Guangzhou, Guangdong, 510080, China
Related Publications (1)
Zhang Y, He X, Chen X, Ma H, Liu D, Luo J, Du Z, Jin Y, Xiong Y, He J, Fang D, Wang K, Lawson WE, Hui JC, Zheng Z, Wu G. Enhanced external counterpulsation inhibits intimal hyperplasia by modifying shear stress responsive gene expression in hypercholesterolemic pigs. Circulation. 2007 Jul 31;116(5):526-34. doi: 10.1161/CIRCULATIONAHA.106.647248. Epub 2007 Jul 9.
PMID: 17620513BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Zhongkai Wu
Department of Cardiovascular Medcine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 28, 2017
First Posted
August 1, 2017
Study Start
September 5, 2017
Primary Completion
August 7, 2020
Study Completion
August 7, 2021
Last Updated
September 7, 2017
Record last verified: 2017-09